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OXYPHENBUTAZONE IN PULMONARY TUBERCULOSIS
DEREK DOYLE, M.B., CH.B. (EDIN.), Nessie Knight Mission Hospital, Sulenkama, Transkei
RESULTS
It will be observed from Tables I - IV that, of the patients
receiving the trial drug, 11 showed an excellent X-ray
response compared with 6 on the placebo, while fewer had
a poor result. The sputum results showed little difference
Ferrous SuIph. Co.BPC was ordered when hypochromic
anaemia was found. A high-protein diet was always given,
often with protein casilate added, and supplemented in all
cases with vitamins. Bed rest was strictly enforced for all
patients involved in the trial.
The Oxyphenbutazone was given as 2 tablets t.ds. in
the first 2 weeks followed by I tab. t.ds. thereafter, until
the completion of 2 months.
Chest X-rays were taken on admission and monthly,
read by one doctor only, who was experienced in interpret-
ing such films. The result was recorded as 'excellent' when
gross signs of exudative disease or numerous soft-walled
cavities had cleared within the 2 months. 'Good' was taken
to mean definite improvement though signs of active
disease persisted, while 'poor' signified little or no improve-
ment at all radiologically.
Sputum was examined microscopically on admission and
at monthly intervals, and bacilli were counted by Gaffky's
method. An 'excellent' result was reported if the sputum
count, previously as high as 8 or 9, was negative by the
end of the 2 months, and if no bacilli were seen during
intensive searching. A 'good' result indicated a definite
lessening of the bacilli count, while 'poor' was applied to
those cases with no change whatsoever.
The ESR was also assessed monthly as an index of the
inflammatory process. Similar criteria were laid down,
namely, 'excellent' when there was a fall from very high
levels (as high as 100 mm.jhour) to normal; 'good' when a
substantial drop occurred, but not to normal levels; and
'poor' when there was no change at all.
Finally the patients' weights were recorded weekly and
a full record kept of all subjective reports on sweating,
depression, possible side-effects, etc.
TABLE I. RADIOLOGICAL CHANGES
Oxyphenbutazone (Tanderil, Geigy) is well known as an
anti-inflammatory agent, and reports on its usefulness in
chronic rheumatic conditions, in most branches of surgery,
and in obstetrics and gynaecology, have appeared in recent
years.'-- Though closely related to phenylbutazone, it is
said to have fewer side-effects.
It has become increasingly clear that there is a place for
anti-inflammatory drugs in the therapy of pulmonary
tuberculosis. Extensive trials have been done on the
corticosteroids being used in this condition' as 'life-savers',
to lessen pulmonary fibrosis, to speed resorption of pleural
effusion, etc., but their potential dangers have become
deterrents to us except in the special cases of tuberculous
meningitis, effusion, and recently developed bronchogenic
disease. Similarly, the newer proteolytic enzymes have been
tried because of their ability to free sputum and improve
ventilation. It was therefore decided to conduct a small
clinical trial of Oxyphenbutazone in this mission hospital,
in the hope that it might improve the sense of well-being
in the depressed Africans whose lives are greatly affected
by the verdict of years of treatment, probably without
work; also that it might lessen cavity formation and lung
scarring and aid the entrance of the tuberculostatics into
the affected lung tissues. A secondary aim was to speed
the treatment so as to release beds quicker for the never-
ending number of people needing hospitalization and to
improve their condition so rapidly that even the lesser edu-
cated ones would be willing to remain here for the neces-
sary time.
Mode of Action
Miller et al.," examining the inflammatory process, pos-
tulated that macromolecular proteins, such as fibrin, form
in the tissue spaces in response to the primary injury. It is
presumed that plasmin, capable of digesting such fibrin,
cannot act because of some inhibitor, as yet not isolated.·
The hydrophilic fibrin causes swelling of the affected part
with resultant capillary stasis and clot formation. Carbon
dioxide builds up in the tissues, while oxygen, antibodies
and antibacterial agents are kept out. Probably the pro-
teolytic enzymes release the plasmin capable of digesting
the fibrin, while the drug under review, Oxyphenbutazone,
competes with the inhibitor, thus permitting the plasmin
to work. It is certainly not a proteolytic enzyme, and it is










TABLE 11. SPUTUM BACILLI COUNTS (GAFFKY)
Drtlg Total Excellent Good Poor
Oxyphenbutazone 25 3 15 7
Placebo 25 4 12 9
TABLE Ill. ESR CHANGES
Drtlg Total Excellent Good Poor
Oxyphenbutazone 25 13 7 5
Placebo 25 9 11 5
TABLE IV. WEIGHT CHANGES
METHOD AND MATERIAL
The 50 patients selected for the trial were proved to have
pulmonary tuberculosis clinically, radiologically, and by
microscopic sputum examination, and they were only used
in the trial if they were considered suitable patients to
receive the 'first-line' drugs, namely streptomycin, neoti-
zide and PAS. If any other tuberculostatics were thought
necessary, the patients were excluded. Twenty-five were
given the trial drug, the others receiving a placebo. No
member of the nursing or laboratory staff was told the
name or nature of the drugs until the completion of the
trial. All routine drugs were prescribed in the usual dosage










A verage weight gain
11 lb.
7 lb.
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between the groups. The ESR results were deemed excel-
lent in 13 of the trialists, compared with only 9 on the
placebo; and substantial weight gain was also noticed in
those receiving the Oxyphenbutazone. It might be noted
here that the latter drug was given to 7 patients with gross
fibrotic disease of long standing whose weight never
changed and in whom there was little radiological improve-
ment. Thus the average gain of 11 lb. in 8 weeks occurred
actually in 18 patients only, some of whom gained more
than 20 lb. in weight.
Clinically it was remarked by the nursing sisters that the
temperatures of those on the trial drug dropped to normal
within 3 days of the commencement of treatment, com-
pared with the usual slow decline in temperature in the
others. The nurses reported, at the end of the trial and
before the nature of the drugs was disclosed, that all
patients receiving Oxyphenbutazone spoke of easier expec-
toration (possibly accounting for the continued presence
of many bacilli shown above), and a definite sense of well-
being with fewer complaints of chest pains, anorexia and
apathy.
Side-Effects
Except for one patient developing stomatitis on the drug,
no side-effects were observed, even though the drug was
administered to patients with a history of cardiac disease,
gastric upset and, in one case, allergy. No leucopenia was
observed.
CONCLUSIONS
A controlled study comparing Oxyphenbutazone (Tan-
deril) and an inert placebo was conducted on 50 patients
with active pulmonary tuberculosis.
It is probably wrong to attempt to draw too many con-
clusions from such a small trial, but it would appear that
the claims made for the anti-inflammatory effects of Oxy-
phenbutazone are worth investigating further in pulmonary
tuberculosis, particularly in those patients with a rapidly
developing exudative type of pathology and a clinical pic-
ture of extreme cachexia. I was impressed with the marked
subjective improvement in the Africans receiving Tanderil,
and have no doubt that it aided their speedier recovery
and earlier hospital discharge.
SUMMARY
The results are published of a small controlled trial of the
anti-inflammatory drug. Oxyphenbutazone, in pulmonary
tuberculosis in African patients. Clinical and radiological
improvement with a fall in ESR were better in the Tan-
deril-treated group as compared with the placebo series. Its
value in speeding the treatment and gaining the coopera-
tion of such patients is noted and the need for a fuller trial
stressed.
I wish to acknowledge my indebtedness to Dr. Dudley
Jacobs of Pharmakers (Pty) Ltd. for both supplying the
Tanderil (Oxyphenbutazone) for the trial and for his constant
interest and encouragement.
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DIE OPVOEDING VAN DIE GENEESHEER*
F. VAN WYK, President Noord-Transvaalse Tak (M.V.S.A.), 1965
Dit het 'n gewoonte geword onder geneeshere om van tyd tot
tyd ons beroep se rol in die samelewing te ontleed. Dit is 'n
goeie gewoonte want alleenlik as ons onsself ontleed, kan ons
foute sien en 'n poging aanwend om hulle uit die weg te ruim.
Ekonomiese probleme het in die afgelope aantal jare sterk op
die voorgrond getree. Die algemene neiging tot sosialisme in
die wlheld gaan ons nie verby nie, en ek dink dat ons almal
terdee besef dat ons vroeer of later ook aan die beurt sal kom.
Dngetwyfeld sal dit nie byval vind by die meeste van ons nie,
en ek is oortuig dat ons dit so lank as moontlik sal teenstaan
om een baie goeie rede, afgesien van die finansiele implikasies;
hierdie rede is dat ons vrees dat dit die hele siel van ons
beroep sal skend en ons sal aftrek na die vlak van die massa.
Dit is tog die neiging vandag om alles en almal gelyk te
maak.
Dns geniet ~andag nog 'n sekere status in die gemeenskap,
en alhoewel die blote woord status deesdae om 'n goeie rede
onsmaaklik geword het, gebruik ek dit omdat dit 'n goeie
beskrywing is van ons posisie in die samelewing. Die feit bly
egter dat dit al moeiliker word om ons huidige status te hand-
haaf. Nie een van ons kan dit betwis dat die beroep nie meer
dieselfde aansien geniet by die publiek as 30 of 50 Jaar gelede
nie. Die dokter van jare gelede is beskou as 'n man van aan-
sien, 'n man van eer, 'n man wat koll. leiding neem; 'n man
by wie jy jou sorge kon uitpraat en beter voel. Tot 'n baie
groot mate is dit nog so, maar dit verander vinnig en die
dokter word al meer en meer beskou as nog 'n noodsaaklike
euwel.
*Presiden tsrede.
Daar is baie redes vir hierdie verskynsel, soos bv. baie van
ons se onfatsoenlike gejaag na geld. 'n Ander rede is die feit
dat meer mense as net dokters, bv. advokate en predikante,
vandag 'n goeie geleerdheid geniet. Nog 'n rede is miskien die
kruipende sosialisme van sekere siektefondse. Maar ten spyte
van al hierdie redes is dit ons plig om onsself af te vra of
daar nie ook by ons 'n fout is nie; of daar nie iets radikaals
verkeerd is in ons beroep nie, en of die publiek nie rniskien 'n
baie goeie rede het om ons in 'n swakker lig te sien as se 50
jaar gelede nie. Dit kan tog nie wees dat ons swakker genees-
here is nie. Dns weet aansienlik meer van siektetoestande, van
medikamente, van operasies, ens., as ons kollegas van 50 jaar
gelede. EintIik behoort ons posisie in die samelewing te ver-
beter en nie agteruit te gaan nie. Waarom is dit dan dat ons
bekommerd voel oor die posisie van die geneesheer?
Afgesien van die moontlikhede wat ek reeds genoem het,
moet ons sterk oorweging skenk aan die feit dat ons tog nie
sulke goeie geneeshere is as wat ons dink nie. Alhoewel die
mediese wetenskap as 'n wetenskap ongekende vooruitgang
gemaak het, is dit tog moontlik dat ons as geneeshere, as die
mense wat die wetenskap moet praktiseer, nie tred gehou het
met hierdie vooruitgang nie. Dit is waarskynlik nie net die
dokters wat gefaal het om by te bly by die moderne tegno-
logiese en wetenskaplike ontwikkeling nie. Kyk maar net na
die politici wat vandag oor magte beskik ver bokant die van
jare gelede. Hulle beskik oor enorme ekonomiese en militere
mag, en tog is internasionale en selfs nasionale verhoudings
in 'n. warboel. Kyk oak maar na die sosioloe en die opvoed-
kundlges. Ten spyte van al hulle kennis en hulpmiddels, soos
